|
|
Pharmacoepidemiology: scrutinizing drug safety in dermatology.
- Article from:
-
Dermatology Times
- Article date:
-
March 1, 2005
- Author:
-
|
Copyright informationCOPYRIGHT 2005 Advanstar Communications, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
New Orleans -- Pharmacoepidemiology, the study of the use and effect of medications used by large numbers of people, is the basic science that informs public health and individual patient care decisions with respect to the use of medications.
According to Joel M. Gelfand, M.D., M.S.C.E., pharmacoepidemiology has timely significance for dermatologists, given recent national publicity focused on the associations of isotretinoin with suicide and lymphoma with psoriasis.
Dr. Gelfand, assistant professor of dermatology and director of the Clinical Studies Unit at the University of Pennsylvania Health System's department of dermatology, addressed such issues in a seminar on ...